News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
51 Results
Type
Article (15)
Press Release (36)
Section
Business (18)
Deals (2)
Drug Development (13)
FDA (1)
Job Trends (1)
News (28)
Policy (3)
Tag
Academia (1)
Alliances (8)
Approvals (1)
Cancer (4)
Clinical research (10)
Collaboration (3)
COVID-19 (4)
C-suite (3)
Data (2)
Diagnostics (1)
Earnings (3)
Events (3)
FDA (2)
GLP-1 (2)
Government (2)
Healthcare (1)
Immuno-oncology (1)
Infectious disease (4)
IPO (1)
Job creations (1)
Legal (1)
Medical device (1)
Medtech (1)
Mergers & acquisitions (2)
People (11)
Phase 1 (7)
Phase 2 (5)
Phase 3 (5)
Pipeline (2)
Preclinical (4)
Regulatory (4)
Research institute (1)
Date
Last 30 days (1)
Last 365 days (10)
2026 (2)
2025 (8)
2024 (2)
2023 (1)
2022 (4)
2021 (6)
2020 (11)
2019 (5)
2018 (3)
2017 (2)
2016 (5)
2010 (1)
Location
Asia (6)
California (1)
Europe (7)
Massachusetts (9)
New York (1)
Southern California (1)
United States (10)
51 Results for "abpro".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference
January 16, 2026
·
5 min read
Press Releases
Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72
January 6, 2026
·
8 min read
Press Releases
Abpro Announces 1-for-30 Reverse Stock Split Effective November 3, 2025
November 4, 2025
·
5 min read
Press Releases
Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers
December 15, 2025
·
7 min read
Press Releases
Abpro and Celltrion to Present Preclinical Data for CT-P72/ABP-102 at SITC 2025, Highlighting a Next-Generation HER2×CD3 T-Cell Engager
November 5, 2025
·
9 min read
Press Releases
Abpro Statement on the Departure of Former CEO Ian Chan
March 11, 2025
·
5 min read
Press Releases
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager
April 28, 2025
·
8 min read
Press Releases
Abpro Announces Closing of Business Combination with Atlantic Coastal Acquisition Corp. II
November 14, 2024
·
2 min read
Press Releases
Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025
March 25, 2025
·
2 min read
Genetown
Abpro to Become Publicly Traded via Merger with Atlantic Coastal Acquisition Corp. II
Abpro Corporation and Atlantic Coastal Acquisition Corp. II announced a term sheet to enter into a definitive business combination, which was entered into on September 18, 2023.
September 21, 2023
·
6 min read
1 of 6
Next
